Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-center, Double Blind, Randomized, Active Controlled Clinical Trial to Evaluate the Non-Inferiority Comparing Cetirizine Injection 10 mg to Diphenhydramine Injection, 50 mg, for the Treatment of Acute Urticaria

NCT02935699 is registered in ClinicalTrials.gov with JDP Therapeutics, Inc. as lead sponsor.

NCT NCT02935699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02935699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-center, Double Blind, Randomized, Active Controlled Clinical Trial to Evaluate the Non-Inferiority Comparing Cetirizine Injection 10 mg to Diphenhydramine Injection, 50 mg, for the Treatment of Acute Urticaria
Lead sponsor
JDP Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
March 1, 2017
Completion date
April 30, 2018
Enrollment
262 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute urticaria